Q atar Foundation established Qatar National Research Fund (QNRF) in 2006 as part of its ongoing commitment to establish Qatar as a knowledge-based economy. Qatar Foundation views research as essential to national and regional growth; as the means to diversify the nation’s economy, enhance educational offerings and develop areas that affect the community, such as health and environment. 

Qatar National Research Fund aims to foster original, competitively selected research in More...


  • Time Zone: Arabia Time Zone UTC+03:00
  • Address: PO Box 5825, Doha, Qatar

أنشأت مؤسسة قطر الصندوق القطري لرعاية البحث العلمي عام 2006 كجزء من التزامها المستمر بإقامة الاقتصاد القائم على المعرفة في دولة قطر. وتولي مؤسسة قطر للبحوث أهمية قصوى استنادًا إلى دورها الحيوي في تحقيق النمو سواء داخل قطر أو على الصعيد الإقليمي، وكونها وسيلة لتنويع اقتصاد البلاد، وتعزيز الفرص التعليمية، وتطوير المجالات المؤثرة في المجتمع كالصحة والبيئة.

ويهدف الصندوق القطري لرعاية البحث العلمي إلى تشجيع الأبحاث المبتكرة المختارة على أساس تنافسي في

المزيد ...

  • التوقيت: توقيت غرينتش +3
  • صندوق البريد: 5825 الدوحة, قطر
  • فاكس: 8079 4454 974
  • الدعم الفني:
  • الموقع الالكتروني:

Friday, March 24, 2023 4:38 PM Doha Time

Online - Research Outcome Seminar

Online - Research Outcome Seminar

Infectious Diseases with Relevance to and Potential Impact on the Pandemic COVID-19

Qatar National Research Fund (QNRF) cordially invites you to attend  a webinar related to the outcome of iits Research-funded (ROS) projects related  to “Infectious Diseases with Relevance to and Potential Impact on the Pandemic COVID-19.”

One of QNRF’s main functions is to facilitate the dissemination of the output of its funded research projects and promote its findings. An important mechanism in this regard are the Research Output Seminars, which highlight the significant outcomes and positive impact of QNRF-funded projects. These seminars are designed as a platform to attract the scientific community and relevant stakeholders, as well as wider public audience to explore collaborations and partnerships between relevant stakeholders and research communities in Qatar.

This ROS is being held at a very important time as the whole world is gripped by the pandemic spread of Coronavirus infection which is forcing governments and public health officials to enforce drastic policies to deal with this emergency while pressure grows on scientists globally to find a cure for the novel virus.

This pandemic has reminded the world that infectious diseases are still a major concern for public health worldwide. Therefore, this ROS is highly relevant as it demonstrates that QNRF has funded several research projects which investigate these infectious diseases. This research has contributed to a better understanding of their epidemiology, diagnosis, and prevention.

Furthermore, this ROS will show how the participating researchers have addressed and created novel methods of dealing with health consequences of infections and restricted the spread of communicable diseases.

Please click the link below to join the webinar: 


Time Topic Presenter
10:00 Welcome
10:00 – 10:15 Overview of QNRF awarded projects related to infectious Diseases Dr. Mohammed H. Jarrar Senior Program Manager, Biomedical Science & Health, Qatar National Research Fund
10:15 – 10:30 The Corona disease contemporary knowledge and updates worldwide

Dr. Shk. Mohammed Al-Thani

Director of Public Health, Supreme Council of Health, MoPH

Presentations of the Projects
10:30 – 10:45 Seroepidemiological Survey of infection with Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Camels and Humans from Butana area - Sudan (2014-2015)

Dr. Elmoubashar Farag / Dr. Mohamed Al-Hajri

Director of Emergency Preparedness and Response Department, CDC Ministry of Public Health

10:45 – 11:00 Variation in Human Leukocyte Antigen Class II Genes and Obesity Independently Modulate the Intensity of Human Antibody Responses to Viral Infection Project Number: PPM1-1220-150017 Dr. Nico Marr Investigator and Group Leader, Systems Immunology and Immune Deficiency, Sidra Medicine
11:00 – 11:15 Facemask against viral respiratory infections: a cluster-randomized trial Project Number: NPRP 6 - 1505 - 3 - 358 Dr. Godwin Wilson / Dr. Osamah Barasheed, (HMC project) Research Center, King Abdullah Medical City, Makkah, Saudi Arabia
11:15 – 11:35 Characterizing hepatitis C virus epidemiology in Qatar and the Middle East and North Africa: Intervention strategies and the path to hepatitis C elimination by 2030. Project Number: NPRP12S-0216-190094 Characterizing the HIV/AIDS epidemics in the Middle East and North Africa: Systematic reviews and quantitative assessments Project Number: NPRP9-040-3-008 (renewal of NPRP 4-924-3-251) Prof. Laith Abu-Raddad Professor of Healthcare Policy and Research, Assistant Dean for Extramural Research Funding, Director of the Areas of Concentration Program, Director of the Biostatistics, Epidemiology and Biomathematics Research Core, Weill Cornell Medicine - Qatar
11:35 – 11:55

Viruses Associated with Acute Gastroenteritis in Qatar. NPRP11S-1212-170092:- Influenza complications and underlying mechanisms in ‎disease pathogenesis in diabetic patients in Qatar. NPRP9-133-1-025:- Estimating the Burden of Viral Gastroenteritis and Effectiveness of ‎Rotavirus Vaccine in Young Children in Qatar

Dr. Hadi M. Yassine Research Projects Manager, Associate Professor of Infectious Diseases, Qatar University

11:55 – 12:15 Molecular epidemiology and seroprevalence of human Papillomavirus in Arab women in the State of Qatar. Project Number: NPRP09-344-3-082 PolyChip – An Ultra High Throughput Microfluidic Functional Assay Strategy for Antimicrobial Drug Discovery. Project Number: NPRP9-001-2-001 Dr. Ali Sultan Professor of Teaching in Microbiology and Immunology, Weill Cornell Medicine – Qatar
12:15 – 12:50 Q&A Session  
12:50 – 1:00 Closing Remarks  
Previous Article Executive Director’s Message
Next Article Invitation to Attend the 12th Annual UREP Competition Online
«March 2023»